Otonomy’s negative Phase III readout calls into question the utility of targeting the glucocorticoid receptor to treat Meniere disease. There are no approved drugs to treat the disorder,
DISEASE CATEGORY: Neurology INDICATION: Anxiety; obsessive compulsive disorder (OCD) Activation of histamine receptor HRH3 in the nucleus accumbens region of the brain could treat anxiety and OCD.